Abstract
In several European Union countries, drug use amongst Black and minority ethnic communities is largely unacknowledged, ignored, unrecognized, or hidden by some policy-makers, drug researchers, drug service planners and commissioners, and by some members of some Black and minority ethnic communities themselves. This article presents evidence to support this statement and suggests ways forward to ensure that the knowledge base on drug use amongst these communities is increased, and drug services are accessible to all who need them. Examples of good practice in engaging members of Black and minority ethnic communities in research and with drug services are provided.
Get full access to this article
View all access options for this article.
